DK3258938T3 - Phenothiazinanaloger som mitokondrie terapeutiske midler - Google Patents
Phenothiazinanaloger som mitokondrie terapeutiske midler Download PDFInfo
- Publication number
- DK3258938T3 DK3258938T3 DK16752964.3T DK16752964T DK3258938T3 DK 3258938 T3 DK3258938 T3 DK 3258938T3 DK 16752964 T DK16752964 T DK 16752964T DK 3258938 T3 DK3258938 T3 DK 3258938T3
- Authority
- DK
- Denmark
- Prior art keywords
- mitocondries
- analoges
- phenothiazine
- therapeutic medicines
- medicines
- Prior art date
Links
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229950000688 phenothiazine Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562117205P | 2015-02-17 | 2015-02-17 | |
| PCT/US2016/018233 WO2016133995A1 (en) | 2015-02-17 | 2016-02-17 | Phenothiazine analogues as mitochondrial therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3258938T3 true DK3258938T3 (da) | 2021-02-01 |
Family
ID=56692740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16752964.3T DK3258938T3 (da) | 2015-02-17 | 2016-02-17 | Phenothiazinanaloger som mitokondrie terapeutiske midler |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10472340B2 (enExample) |
| EP (1) | EP3258938B1 (enExample) |
| JP (3) | JP6807337B2 (enExample) |
| AU (3) | AU2016220096B2 (enExample) |
| CA (1) | CA2976776C (enExample) |
| DK (1) | DK3258938T3 (enExample) |
| WO (1) | WO2016133995A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016220153B2 (en) | 2015-02-17 | 2020-07-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| WO2016133995A1 (en) | 2015-02-17 | 2016-08-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Phenothiazine analogues as mitochondrial therapeutic agents |
| US10604501B2 (en) | 2016-06-15 | 2020-03-31 | Arizona Board Of Regents On Behalf Of Arizona State University | Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting |
| WO2018039487A1 (en) | 2016-08-25 | 2018-03-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US11390605B2 (en) | 2016-08-25 | 2022-07-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses |
| WO2018129411A1 (en) * | 2017-01-06 | 2018-07-12 | Bioelectron Technology Corporation | Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders |
| FR3063495B1 (fr) * | 2017-03-02 | 2019-04-05 | Provepharm Life Solutions | Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium |
| CN114181170B (zh) * | 2018-04-27 | 2023-03-10 | 成都恒昊创新科技有限公司 | 一种10h-吩噻嗪类铁死亡抑制剂及其制备方法与应用 |
| JP7522095B2 (ja) * | 2018-07-22 | 2024-07-24 | ミノヴィア セラピューティクス リミテッド | 原発性ミトコンドリア病のためのミトコンドリア増強療法 |
| EP3826639B1 (en) * | 2018-07-26 | 2024-08-21 | WisTa Laboratories Ltd. | Optimised dosage of diaminophenothiazines in populations |
| US12110313B2 (en) | 2019-02-28 | 2024-10-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Engineered bacterial ribosome compositions and methods |
| CN116848101A (zh) * | 2021-02-09 | 2023-10-03 | 勃林格殷格翰国际有限公司 | 复合体i的调节剂 |
| CN119504646A (zh) * | 2024-11-07 | 2025-02-25 | 长春工业大学 | 新型含有吩噻嗪结构药物小分子的合成及抗肿瘤活性研究 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3476722A (en) | 1966-08-15 | 1969-11-04 | Goodrich Co B F | Process for polymerizing acrylic acid esters |
| DE2315349A1 (de) | 1973-03-28 | 1974-10-03 | Bayer Ag | Nicht verfaerbende alterungsschutzmittel |
| JPS5168569A (en) | 1974-12-10 | 1976-06-14 | Fuji Photo Film Co Ltd | 2 2 44 torimechiru 66 hidorokishi 77 chikankuromanruino seizoho |
| FR2471052B1 (fr) * | 1979-11-28 | 1985-10-11 | Kuraray Co | Photo-electrode pour cellule photo-electrochimique et son procede de fabrication |
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US5220042A (en) | 1984-01-26 | 1993-06-15 | Otsuka Pharmaceutical Co., Ltd. | 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| JPH06505239A (ja) | 1991-01-31 | 1994-06-16 | ワーナー−ランバート・コンパニー | 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体 |
| AU5527196A (en) | 1995-04-04 | 1996-10-23 | Brigham And Women's Hospital | Inhibiting retroviral replication |
| JP2001209176A (ja) | 1999-04-02 | 2001-08-03 | Fuji Photo Film Co Ltd | 光重合性組成物およびそれを用いた記録材料 |
| CN1438890A (zh) | 2000-02-25 | 2003-08-27 | 弗·哈夫曼-拉罗切有限公司 | 腺苷受体调制剂 |
| WO2002000683A2 (en) | 2000-06-23 | 2002-01-03 | Vanderbilt University | Novel chain-breaking antioxidants |
| US20040248913A1 (en) | 2001-07-20 | 2004-12-09 | Grese Timothy Alan | (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| MXPA04012559A (es) * | 2002-06-17 | 2005-09-21 | Verification Technologies Inc | Materiales para proteccion contra copias de medio optico que reacciona transitoriamente a un haz de lector. |
| ATE459725T1 (de) | 2002-11-18 | 2010-03-15 | Panomics Inc | Caged-sensoren, -regulatoren und-verbindungen sowie verwendungen davon |
| US20060188866A1 (en) | 2005-02-18 | 2006-08-24 | Children's Hospital Oakland Research Institute | Diaminophenothiazine compositions and uses thereof |
| EP1863796A1 (en) | 2005-03-22 | 2007-12-12 | NeuroSearch A/S | Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use |
| HUE030621T2 (en) | 2006-07-11 | 2017-05-29 | Wista Lab Ltd | Methods for the synthesis and / or purification of diaminophenothiazinium compounds |
| CN101820884B (zh) | 2007-06-19 | 2013-08-28 | 维斯塔实验室有限公司 | 用于治疗轻度认知缺损的吩噻嗪化合物 |
| US8268849B2 (en) | 2007-09-25 | 2012-09-18 | Board Of Regents Of The University Of Nebraska | Multifunctional Antioxidants and methods of use thereof |
| EP2268311A4 (en) | 2008-04-04 | 2014-08-27 | Immunolight Llc | NON-INVASIVE SYSTEMS AND IN SITU PHOTOBIOMODULATION METHODS |
| US8389583B2 (en) | 2008-05-23 | 2013-03-05 | Zurex Pharma, Inc. | Antimicrobial compositions and methods of use |
| CA2784830C (en) | 2009-12-18 | 2018-03-27 | Sunovion Pharmaceuticals Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| ES2687177T3 (es) | 2010-02-19 | 2018-10-24 | Arizona Board Of Regents, A body corporate of the State of Arizona acting, For and on behalf of Arizona State University | Inhibidores de radicales multifuncionales y su uso |
| US8785434B2 (en) * | 2010-04-30 | 2014-07-22 | Prosetta Antiviral Inc. | Antiviral compounds |
| WO2012022467A2 (en) | 2010-08-16 | 2012-02-23 | Santhera Pharmaceuticals (Schweiz) Ag | Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function |
| DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
| EP2450893A1 (de) * | 2010-11-08 | 2012-05-09 | Bayer MaterialScience AG | Photopolymer-Formulierung zur Herstellung holographischer Medien mit hoch vernetzten Matrixpolymeren |
| US8759336B2 (en) | 2011-03-17 | 2014-06-24 | Prosetta Antiviral Inc. | Antiviral compounds |
| AU2012240263B2 (en) | 2011-04-04 | 2017-04-13 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Multifunctional radical quenchers for the treatment of mitochondrial dysfunction |
| KR101270160B1 (ko) | 2011-05-16 | 2013-05-31 | 아주대학교산학협력단 | 가변색 이광자 형광프로브, 이를 이용한 미토콘드리아 내 티올 활성의 영상화 방법 및 이의 제조방법 |
| WO2013120081A1 (en) | 2012-02-10 | 2013-08-15 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | 1h- pyrrolo [2, 3 -b] pyridine derivatives and their use as radical quenchers |
| WO2013120040A1 (en) | 2012-02-10 | 2013-08-15 | Children's Medical Center Corporation | Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy |
| WO2014055629A1 (en) | 2012-10-03 | 2014-04-10 | Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona | Multifunctional radical quenchers for the treatment of mitochondrial dysfunction |
| AU2013329171A1 (en) | 2012-10-10 | 2015-04-30 | Arizona Board Of Regents, On Behalf Of Arizona State University | Multifunctional radical quenchers |
| US20140275045A1 (en) | 2013-03-15 | 2014-09-18 | Edison Pharmaceuticals, Inc. | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
| WO2016133995A1 (en) | 2015-02-17 | 2016-08-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Phenothiazine analogues as mitochondrial therapeutic agents |
| AU2016220153B2 (en) | 2015-02-17 | 2020-07-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10604501B2 (en) | 2016-06-15 | 2020-03-31 | Arizona Board Of Regents On Behalf Of Arizona State University | Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting |
| WO2018039487A1 (en) | 2016-08-25 | 2018-03-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US11390605B2 (en) | 2016-08-25 | 2022-07-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses |
-
2016
- 2016-02-17 WO PCT/US2016/018233 patent/WO2016133995A1/en not_active Ceased
- 2016-02-17 EP EP16752964.3A patent/EP3258938B1/en active Active
- 2016-02-17 JP JP2017561611A patent/JP6807337B2/ja not_active Expired - Fee Related
- 2016-02-17 AU AU2016220096A patent/AU2016220096B2/en active Active
- 2016-02-17 CA CA2976776A patent/CA2976776C/en active Active
- 2016-02-17 US US15/550,282 patent/US10472340B2/en active Active
- 2016-02-17 DK DK16752964.3T patent/DK3258938T3/da active
-
2019
- 2019-10-21 US US16/659,308 patent/US11034662B2/en active Active
-
2020
- 2020-04-29 AU AU2020202836A patent/AU2020202836B2/en not_active Ceased
- 2020-10-07 JP JP2020169793A patent/JP7113055B2/ja active Active
-
2021
- 2021-02-22 AU AU2021201137A patent/AU2021201137A1/en not_active Abandoned
- 2021-04-28 US US17/243,005 patent/US20220081404A1/en not_active Abandoned
-
2022
- 2022-07-25 JP JP2022118006A patent/JP2022141896A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018505228A (ja) | 2018-02-22 |
| CA2976776A1 (en) | 2016-08-25 |
| AU2020202836A1 (en) | 2020-05-21 |
| US20220081404A1 (en) | 2022-03-17 |
| JP2022141896A (ja) | 2022-09-29 |
| US20180065941A1 (en) | 2018-03-08 |
| JP2021006573A (ja) | 2021-01-21 |
| WO2016133995A1 (en) | 2016-08-25 |
| US20200115355A1 (en) | 2020-04-16 |
| EP3258938A1 (en) | 2017-12-27 |
| EP3258938B1 (en) | 2020-12-02 |
| AU2016220096B2 (en) | 2020-01-30 |
| JP6807337B2 (ja) | 2021-01-06 |
| AU2016220096A1 (en) | 2017-08-31 |
| US10472340B2 (en) | 2019-11-12 |
| EP3258938A4 (en) | 2018-10-31 |
| US11034662B2 (en) | 2021-06-15 |
| CA2976776C (en) | 2023-06-20 |
| JP7113055B2 (ja) | 2022-08-04 |
| AU2020202836B2 (en) | 2020-12-17 |
| AU2021201137A1 (en) | 2021-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281863A (en) | Pharmaceutical compositions comprising meloxicam | |
| IL282304A (en) | Topical pharmaceutical compositions | |
| DK3328880T3 (da) | Terapeutiske midler | |
| EP3344318A4 (en) | Patient interfaces | |
| DK3229810T3 (da) | Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler | |
| IL253719B (en) | Pharmaceutical compositions for combination therapy | |
| DK3258938T3 (da) | Phenothiazinanaloger som mitokondrie terapeutiske midler | |
| EP3522966A4 (en) | PATIENT INTERFACES | |
| DK3265421T3 (da) | Doseringssystem | |
| SI3529248T1 (sl) | Farmacevtske spojine | |
| DK3722274T3 (da) | 2-perfluorbutylpentan til oftalmisk indgivelse | |
| PL4070788T3 (pl) | Formulacje farmaceutyczne | |
| HUE054344T2 (hu) | Gyógyászati készítmények AZD9291 tartalommal | |
| BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| EP3424940A4 (en) | Radiolabeled drug | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3380146T3 (da) | Medikamentadministrationsanordning | |
| EP3246047C0 (en) | COMBINATION MEDICATION | |
| EP3437644A4 (en) | MEDICINE | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| EP3527216A4 (en) | Medicine | |
| EP3337463A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3728220T3 (da) | Farmaceutiske forbindelser |